Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT00329043

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

A Phase II Neoadjuvant Trial of Sunitinib Malate (SU011248) Plus Hormonal Ablation for Patients Who Have High Risk Localized Prostate Cancer and Will Undergo Prostatectomy

Sponsor: M.D. Anderson Cancer Center

Conditions Prostate Cancer

Interventions LHRH Agonist Radical Prostatectomy Sunitinib Malate

Updated 24 times since 2017 Last updated: Dec 23, 2025 Started: May 15, 2006 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Prostate Cancer and is currently ongoing. M.D. Anderson Cancer Center leads this study, which shows 24 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

24 versions recorded

Jan 2026 — Present [monthly]

Active Not Recruiting PHASE2
Dec 2025 — Jan 2026 [monthly]

Active Not Recruiting PHASE2
Jun 2025 — Dec 2025 [monthly]

Active Not Recruiting PHASE2
Jan 2025 — Jun 2025 [monthly]

Active Not Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Active Not Recruiting PHASE2

▶ Show 19 earlier versions

Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2
Jun 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE2
May 2024 — Jun 2024 [monthly]

Active Not Recruiting PHASE2
Nov 2023 — May 2024 [monthly]

Active Not Recruiting PHASE2
Jul 2023 — Nov 2023 [monthly]

Active Not Recruiting PHASE2
May 2023 — Jul 2023 [monthly]

Active Not Recruiting PHASE2
Jan 2023 — May 2023 [monthly]

Active Not Recruiting PHASE2
Jul 2022 — Jan 2023 [monthly]

Active Not Recruiting PHASE2
May 2022 — Jul 2022 [monthly]

Active Not Recruiting PHASE2
Oct 2021 — May 2022 [monthly]

Active Not Recruiting PHASE2
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting PHASE2
Jul 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2
Dec 2019 — Jul 2020 [monthly]

Active Not Recruiting PHASE2
Oct 2019 — Dec 2019 [monthly]

Active Not Recruiting PHASE2
Jun 2019 — Oct 2019 [monthly]

Active Not Recruiting PHASE2
Jun 2018 — Jun 2019 [monthly]

Active Not Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE2
Feb 2017 — Oct 2017 [monthly]

Active Not Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

M.D. Anderson Cancer Center
Pfizer

Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States